ZEPP HEALTH CORP-ADR (ZEPP) Fundamental Analysis & Valuation

NYSE:ZEPP • US98945L2043

Current stock price

16.89 USD
+0.13 (+0.78%)
Last:

This ZEPP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ZEPP Profitability Analysis

1.1 Basic Checks

  • ZEPP had negative earnings in the past year.
  • In the past 5 years ZEPP reported 4 times negative net income.
  • ZEPP had negative operating cash flow in 4 of the past 5 years.
ZEPP Yearly Net Income VS EBIT VS OCF VS FCFZEPP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

  • ZEPP has a Return On Assets of -7.09%. This is in the lower half of the industry: ZEPP underperforms 62.10% of its industry peers.
  • Looking at the Return On Equity, with a value of -18.68%, ZEPP is doing worse than 66.13% of the companies in the same industry.
Industry RankSector Rank
ROA -7.09%
ROE -18.68%
ROIC N/A
ROA(3y)-8.77%
ROA(5y)-5.94%
ROE(3y)-19.21%
ROE(5y)-12.81%
ROIC(3y)N/A
ROIC(5y)N/A
ZEPP Yearly ROA, ROE, ROICZEPP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 -30

1.3 Margins

  • With a decent Gross Margin value of 38.31%, ZEPP is doing good in the industry, outperforming 62.90% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ZEPP has grown nicely.
  • The Profit Margin and Operating Margin are not available for ZEPP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.49%
GM growth 5Y13.09%
ZEPP Yearly Profit, Operating, Gross MarginsZEPP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ZEPP Health Analysis

2.1 Basic Checks

  • ZEPP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ZEPP has been reduced compared to 1 year ago.
  • ZEPP has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ZEPP is higher compared to a year ago.
ZEPP Yearly Shares OutstandingZEPP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
ZEPP Yearly Total Debt VS Total AssetsZEPP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • ZEPP has an Altman-Z score of 2.00. This is not the best score and indicates that ZEPP is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.00, ZEPP is not doing good in the industry: 63.71% of the companies in the same industry are doing better.
  • ZEPP has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.06, ZEPP is doing worse than 87.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Altman-Z 2
ROIC/WACCN/A
WACC6.29%
ZEPP Yearly LT Debt VS Equity VS FCFZEPP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 1.02 indicates that ZEPP should not have too much problems paying its short term obligations.
  • ZEPP has a Current ratio of 1.02. This is amonst the worse of the industry: ZEPP underperforms 89.52% of its industry peers.
  • ZEPP has a Quick Ratio of 1.02. This is a bad value and indicates that ZEPP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.77, ZEPP is doing worse than 87.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.77
ZEPP Yearly Current Assets VS Current LiabilitesZEPP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ZEPP Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 46.14% over the past year.
  • The Revenue has grown by 41.78% in the past year. This is a very strong growth!
  • ZEPP shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -22.61% yearly.
EPS 1Y (TTM)46.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.14%
Revenue 1Y (TTM)41.78%
Revenue growth 3Y-25.08%
Revenue growth 5Y-22.61%
Sales Q2Q%43.04%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y58.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year26.12%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZEPP Yearly Revenue VS EstimatesZEPP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B
ZEPP Yearly EPS VS EstimatesZEPP Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 10 -10 20 30

More info and screens

Find the best growth stocksShow best growing peers

0

4. ZEPP Valuation Analysis

4.1 Price/Earnings Ratio

  • ZEPP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ZEPP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZEPP Price Earnings VS Forward Price EarningsZEPP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZEPP Per share dataZEPP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ZEPP Dividend Analysis

5.1 Amount

  • ZEPP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ZEPP Fundamentals: All Metrics, Ratios and Statistics

ZEPP HEALTH CORP-ADR

NYSE:ZEPP (4/27/2026, 4:15:00 PM)

16.89

+0.13 (+0.78%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)03-24
Earnings (Next)05-18
Inst Owners62.67%
Inst Owner Change0%
Ins Owners7.64%
Ins Owner Change0%
Market Cap1.01B
Revenue(TTM)258.90M
Net Income(TTM)-40.07M
Analysts85
Price Target63.07 (273.42%)
Short Float %13.38%
Short Ratio3.92
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.91
P/FCF N/A
P/OCF N/A
P/B 4.72
P/tB 5.29
EV/EBITDA N/A
EPS(TTM)-0.66
EYN/A
EPS(NY)-0.37
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.32
BVpS3.58
TBVpS3.19
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -7.09%
ROE -18.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.31%
FCFM N/A
ROA(3y)-8.77%
ROA(5y)-5.94%
ROE(3y)-19.21%
ROE(5y)-12.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.49%
GM growth 5Y13.09%
F-ScoreN/A
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.77
Altman-Z 2
F-ScoreN/A
WACC6.29%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.14%
EPS Next Y58.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)41.78%
Revenue growth 3Y-25.08%
Revenue growth 5Y-22.61%
Sales Q2Q%43.04%
Revenue Next Year26.12%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y38.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year87.27%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

ZEPP HEALTH CORP-ADR / ZEPP Fundamental Analysis FAQ

What is the fundamental rating for ZEPP stock?

ChartMill assigns a fundamental rating of 1 / 10 to ZEPP.


What is the valuation status for ZEPP stock?

ChartMill assigns a valuation rating of 0 / 10 to ZEPP HEALTH CORP-ADR (ZEPP). This can be considered as Overvalued.


What is the profitability of ZEPP stock?

ZEPP HEALTH CORP-ADR (ZEPP) has a profitability rating of 1 / 10.


Can you provide the financial health for ZEPP stock?

The financial health rating of ZEPP HEALTH CORP-ADR (ZEPP) is 2 / 10.